Actively Recruiting
Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father
Led by Groupe Hospitalier du Havre · Updated on 2026-01-21
1000
Participants Needed
2
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on fathers during the perinatal period, a time of significant psychological changes, identity challenges, anxiety, and risk of depression. The study aims to validate the Edinburgh Postnatal Depression Scale (EPDS) as a screening tool for postnatal depression specifically in French fathers, addressing a gap since EPDS is widely used for women but not yet validated for men in this context. Fathers participate by completing the PH-Q9, EPDS, and socio-demographic questionnaires online at the start of the study and again 6 to 8 weeks after their child's birth. Those included at the maternity hospital or through their wives also undergo the Mini International Neuropsychiatric Interview (MINI) at inclusion, which is a standard diagnostic tool for postnatal depression. Fathers recruited via an awareness campaign complete the questionnaires but do not have the MINI interview. Participants will be assessed twice: at inclusion and 6 to 8 weeks postpartum, with those at maternity wards also receiving the MINI interview at inclusion. Researchers will measure depression risk using EPDS and confirm diagnosis with MINI. The study includes socio-demographic data collection, with no masking or randomization. Participation involves online questionnaires and an interview for some, with the overall goal to improve screening methods for paternal postnatal depression.
CONDITIONS
Brief Title
Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All fathers whose baby is 10 days old or less
You will not qualify if you...
- People with a poor understanding of spoken or written French
- Minors
- Persons under court protection, guardianship or curatorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 6 to 8 weeks
Participants complete online questionnaires about their mood and socio-demographic information at inclusion and 6 to 8 weeks after the birth of their child. Fathers included at the maternity hospital also take a diagnostic interview for postnatal depression at inclusion.
2 online assessments: one at inclusion and one 6 to 8 weeks after birth
Trial Site Locations
Total: 2 locations
1
Antoine-Béclère hospital AP-HP
Clamart, France, 92140
Enrolling by Invitation
2
Le Havre hospital - site Jacques Monod
Montivilliers, France, 76290
Actively Recruiting
Research Team
A
Angélique PICARD, project coordinator
C
Christophe FRUIT, CRA
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here